Vigabatrin
Limited data
Limited data
Sparse data. Doses and effects may be unreliable or untested.
- 1 source
- no dose data
- PubChem toxicity data
Limited data
Sparse data. Doses and effects may be unreliable or untested.
- 1 source
- no dose data
- PubChem toxicity data
Summary
Vigabatrin is an antiepileptic (anticonvulsant) medication, sold under the brand name Sabril. It irreversibly inhibits GABA transaminase, raising brain GABA levels, and is used to treat refractory complex partial seizures and infantile spasms. It is not a recreational drug; long-term use carries a risk of permanent peripheral vision loss.
Tolerance
Build-up
develops over 1–4 weeks of regular use
Reset
days to weeks depending on duration of use
Tolerance Decay
Full tolerance
3d
Half tolerance
8d
Baseline
~14d
Effects
Effect glossary — · full glossary
Positive
Negative
Positive
Negative
Positive
Negative
Pill Identifiers
2
known pill identifiers on record — view imprints, colors, shapes, and images
→
Vigabatrin's nerd page
Pharmacology, chemical data, effect profiles, and more
→
Helpful Links
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for Vigabatrin? Let us know. Reports are reviewed by moderators — this is not posted publicly.